Opportunity
Federal Register #2026-12074
NIH Center for Scientific Review Closed Meetings for Proposal and Grant Evaluation
Buyer
National Institutes of Health
Posted
June 16, 2026
Respond By
July 16, 2026
Identifier
2026-12074
This notice concerns a series of closed meetings organized by the National Institutes of Health (NIH), Center for Scientific Review. - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - Center for Scientific Review - Purpose of Meetings: - Review and evaluation of contract proposals and grant applications in scientific and medical research fields - Topics include: alcohol registry contracts, neurovascular and blood-brain barrier studies, musculoskeletal and oral sciences fellowships, pharmacotherapeutic and immunotherapeutic agents, biodata management, nervous system technologies, animal and biological resource centers, infectious diseases and immunology fellowships, autoimmunity, immunology and transplantation, kidney, urology, and skin fellowships - Confidentiality: - Meetings are closed to the public due to discussion of trade secrets, commercial property, and personal information - No procurement activity: - No products or services are being requested or awarded - No OEMs or vendors are mentioned
Description
This notice from the National Institutes of Health's Center for Scientific Review announces a series of closed meetings scheduled for July 2026. The meetings will review and evaluate contract proposals and grant applications related to various scientific and medical research areas, including alcohol registry contracts, neurovascular and blood-brain barrier studies, musculoskeletal and oral sciences fellowships, pharmacotherapeutic and immunotherapeutic agents, biodata management, nervous system technologies, animal and biological resource centers, infectious diseases and immunology fellowships, autoimmunity, immunology and transplantation topics, and kidney, urology, and skin fellowships. These meetings are closed to the public due to the confidential nature of the grant applications and discussions, which may involve trade secrets, commercial property, and personal information.